in this summary report of the workshop , primarily covering amoxapine , maprotiline , trazodone , and the investigational drug bupropion , the authors note that none of the new antidepressants demonstrate greater effectiveness than standard tricyclics , although some produce a different profile of side effects .
C0002644
amoxapine
C0003289
antidepressants